Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Epoetin beta 20,000units/0.6ml solution for injection pre-filled syringes |
| BNF code | 0901030E0AAAXAX |
| Virtual Therapeutic Moiety | Epoetin beta |
| Abbreviated name | Epoetin beta 20,000units/0.6ml inj pre-filled syringes |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Date of name applicability | 19 May 2004 |
| Previous name | Epoetin beta 33,333units/ml injection 0.6ml pre-filled syringes |
| Basis of previous name | rINN - Recommended International Non-proprietary |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 0.600 |
| Unit dose form units | ml |
| Unit dose unit of measure | pre-filled disposable injection |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Epoetin beta |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 33333.000 |
| Strength value numerator unit | unit |
| Strength value denominator | 1.000 |
| Strength value denominator unit | ml |
| Ontology Drug Form & Route | |
| Form & Route | solutioninjection.intravenous |
| Ontology Drug Form & Route | |
| Form & Route | solutioninjection.subcutaneous |
| Dose Form | |
| Formulation | Solution for injection |
| Drug Route | |
| Route | Subcutaneous |
| Drug Route | |
| Route | Intravenous |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| NeoRecormon 20,000units/0.6ml solution for injection pre-filled syringes (Roche Products Ltd) | |
| Virtual Medicinal Product Packs | |
| Epoetin beta 20,000units/0.6ml solution for injection pre-filled syringes 6 pre-filled disposable injection | |
dm+d data retrieved from TRUD: release NHSBSA_4.2.0_20240415000001, imported on 15th April 2024 at 05:09:22.